nach oben

Osteoporosis International

Erschienen in:

01.01.2015 | Case Report

Alendronate-induced unmasking or deterioration of coeliac disease: a case series

verfasst von: B. G. A. Stuckey, R. Sallie

Erschienen in: Osteoporosis International | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Osteoporosis is an increasing health problem in an ageing population. Bisphosphonates are one class of effective treatments. …

Fleisch H (1993) Bisphosphonates: mechanisms of action and clinical use. In: Mundy GR, Martin TJ (eds) Physiology and pharmacology of bone, Handbook of experimental pharmacology. Springer-Verlag Berlin Heidelberg, New York, pp 377–418CrossRef

Kemppainen T, Kroger H, Janatuinen E, Arnala I, Kosma VM, Pikkarainen P, Julkunen R, Jurvelin J, Alhava E, Uusitupa M (1999) Osteoporosis in adult patients with celiac disease. Bone 24:249–255PubMedCrossRef

Pistorius LR, Sweidan WH, Purdie DW, Steel SA, Howey S, Bennett JR, Sutton DR (1995) Coeliac disease and bone mineral density in adult female patients. Gut 37:639–642PubMedCentralPubMedCrossRef

Lindh E, Ljunghall S, Larsson K, Lavo B (1992) Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med 231:403–406PubMedCrossRef

Lebwohl B, Michaëlsson K, Green PHR, Ludvigsson JF (2014) Persistent mucosal damage and risk of fracture in celiac disease. J Clin Endocrinol Metab 99:609–616PubMedCrossRef

Collin P, Kaukinen K, Maki M (1999) Clinical features of celiac disease today. Dig Dis 17:100–106PubMedCrossRef

Bianchi ML, Bardella MT (2008) Bone in celiac disease. Osteoporos Int 19:1705–1716PubMedCrossRef

Moss SF, Attia L, Scholes JV, Walters JRF, Holt PR (1996) Increased small intestinal apoptosis in coeliac disease. Gut 39:811–817PubMedCentralPubMedCrossRef

Giovanni C, Sanchez M, Straface E, Scazzocchio B, Silano M, Md V (2000) Induction of apoptosis in Caco-2 cells by wheat gliadin peptides. Toxicology 145:63–71CrossRef

10.

Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB (1995) Effect of alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437–1443PubMedCrossRef

11.

Bauer DC, Black D, Ensrud K, Thompson D, Hochberg M, Nevitt M, Musliner T, Freedholm D (2000) Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med 160:517–525PubMedCrossRef

12.

Kelly R, Taggart H (1997) Incidence of gastrointestinal side effects due to alendronate is high in clinical practice. Br Med J 315:1235CrossRef

13.

de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tillotson S, Seleznick MJ, Pinkas H, Wang KK (1996) Esophagitis associated with the use of alendronate. N Engl J Med 335:1016–1021PubMedCrossRef

14.

Parfitt JR, Driman DK (2007) Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol 38:527–536PubMedCrossRef

15.

Peng YL, Hu HY, Luo JC, Hou MC, Lin HC, Lee FY (2014) Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study. Osteoporos Int 25:1617–1623PubMedCrossRef

16.

Mok JO, Jung CH, Kim CH, Ryu CB, Kim YJ, Kim SJ, Park HK, Suh KI, Yoo MH, Byun D-W (2013) Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females. Korean J Intern Med 28:694–700PubMedCentralPubMedCrossRef

17.

Twiss IM, Pas O, Ramp-Koopmanschap W, Den Hartigh J, Vermeij P (1999) The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium. J Bone Miner Res 14:784–791PubMedCrossRef

18.

Twiss IM, van den Berk AHM, de Kam ML, Bosch JJ, Cohen AF, Vermeij P, Burggraaf J (2006) A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans. J Clin Pharmacol 46:483–487PubMedCrossRef

19.

eHealthMe. http://www.ehealthme.com/ds/fosamax/celiac+disease+−+sprue. Accessed 5 Oct 2014

20.

Meek SE, Nix K (2007) Hypocalcemia after alendronate therapy in a patient with celiac disease. Endocr Pract 13:403–407PubMedCrossRef

21.

Lewis NR, Scott BB, for the British Society of Gastroenterology (2007) Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease. http://www.bsg.org.uk/clinical-guidelines/ibd/guidelines-for-osteoporosis-in-inflammatory-bowel-disease-and-coeliac-disease.html. Accessed 23 Oct 2014

Titel: Alendronate-induced unmasking or deterioration of coeliac disease: a case series
verfasst von: B. G. A. Stuckey
R. Sallie
Publikationsdatum: 01.01.2015
Verlag: Springer London
Erschienen in: Osteoporosis International / Ausgabe 1/2015
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-014-2942-8

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Alendronate-induced unmasking or deterioration of coeliac disease: a case series

Excerpt

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Update Orthopädie und Unfallchirurgie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Effects of hip abductor muscle forces and knee boundary conditions on femoral neck stresses during simulated falls

Estrogens, the be-all and end-all of male hypogonadal bone loss?

The incidence of hip fractures in Estonia, 2005–2012

Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD

Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients

Magnitude of fragility fracture risk in the very old—are we meeting their needs? The Newcastle 85+ Study

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Update Orthopädie und Unfallchirurgie